IRIS
RUSCITTI, PIERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.941
AS - Asia 5.584
EU - Europa 5.209
SA - Sud America 763
AF - Africa 105
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 11
Totale 21.625
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.784
SG - Singapore 2.638
RU - Federazione Russa 1.459
IE - Irlanda 1.395
CN - Cina 1.046
BR - Brasile 662
HK - Hong Kong 626
VN - Vietnam 549
IT - Italia 445
DE - Germania 395
SE - Svezia 359
TR - Turchia 327
UA - Ucraina 228
GB - Regno Unito 227
FR - Francia 198
FI - Finlandia 160
NL - Olanda 114
IN - India 104
CA - Canada 82
JP - Giappone 66
MX - Messico 52
BE - Belgio 46
ZA - Sudafrica 43
AR - Argentina 41
BD - Bangladesh 38
PL - Polonia 34
ES - Italia 29
LT - Lituania 27
CZ - Repubblica Ceca 23
ID - Indonesia 23
IQ - Iraq 22
EC - Ecuador 17
PK - Pakistan 15
AT - Austria 14
KR - Corea 13
VE - Venezuela 13
JO - Giordania 11
MA - Marocco 11
SA - Arabia Saudita 11
TN - Tunisia 10
AE - Emirati Arabi Uniti 9
EU - Europa 9
GR - Grecia 9
AZ - Azerbaigian 8
CH - Svizzera 8
CO - Colombia 8
DZ - Algeria 8
EG - Egitto 8
IL - Israele 8
PH - Filippine 8
RO - Romania 8
UZ - Uzbekistan 8
KE - Kenya 7
LB - Libano 7
PY - Paraguay 7
AL - Albania 6
AU - Australia 6
KZ - Kazakistan 6
NP - Nepal 6
KW - Kuwait 5
BO - Bolivia 4
DO - Repubblica Dominicana 4
JM - Giamaica 4
LU - Lussemburgo 4
MK - Macedonia 4
MY - Malesia 4
PE - Perù 4
SN - Senegal 4
UY - Uruguay 4
CI - Costa d'Avorio 3
CL - Cile 3
DK - Danimarca 3
HN - Honduras 3
HR - Croazia 3
MM - Myanmar 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
OM - Oman 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
EE - Estonia 2
ET - Etiopia 2
GH - Ghana 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MO - Macao, regione amministrativa speciale della Cina 2
PA - Panama 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AO - Angola 1
BB - Barbados 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
CG - Congo 1
CR - Costa Rica 1
Totale 21.607
Salva come PNG Salva come JPEG
Città #
Dublin 1.392
Singapore 1.351
Dallas 1.203
Chandler 1.137
San Jose 1.131
Jacksonville 942
Ashburn 761
Hong Kong 618
Santa Clara 547
Boardman 388
The Dalles 316
New York 298
Moscow 262
Izmir 208
Beijing 194
Ho Chi Minh City 168
Los Angeles 163
Lawrence 161
Princeton 161
Ann Arbor 151
Nanjing 125
Hanoi 124
Wilmington 123
Lauterbourg 100
L'aquila 99
Amsterdam 96
Council Bluffs 93
San Mateo 83
Hefei 79
Munich 79
São Paulo 70
Tokyo 66
Columbus 63
Dearborn 63
L’Aquila 62
Woodbridge 55
Helsinki 52
Milan 50
Nanchang 50
Orem 48
Lappeenranta 47
Shanghai 42
Brussels 41
Frankfurt am Main 38
Seattle 38
Assago 32
Des Moines 32
Stockholm 31
Brooklyn 30
Da Nang 30
Dong Ket 30
Johannesburg 30
Mountain View 30
Shenyang 30
Houston 29
Kunming 29
Montreal 29
Chicago 28
Phoenix 28
Warsaw 28
Manchester 26
Haiphong 25
Hebei 24
London 24
Pescara 23
Chennai 22
Mexico City 22
Tianjin 22
Jinan 21
Rio de Janeiro 21
Brno 20
Denver 20
Jiaxing 19
Kitzingen 19
Mumbai 19
New Delhi 19
Rome 19
San Francisco 19
Verona 19
Ankara 18
Atlanta 18
Cedar Knolls 17
Changsha 17
Falkenstein 17
Jakarta 17
Pune 17
Zhengzhou 17
Guangzhou 16
Boston 14
Poplar 14
Toronto 14
Turku 14
Belo Horizonte 13
Porto Alegre 13
Brasília 12
Ningbo 12
Norwalk 12
Washington 12
Amman 11
Bremen 11
Totale 14.493
Salva come PNG Salva come JPEG
Nome #
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 175
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 170
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 158
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 157
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 154
Evaluating the multivisceral involvement on adult-onset Still’s disease to retrieve imaging-based differences in patients with and without macrophage activation syndrome: results from a single-centre observational study 154
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 153
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 152
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 149
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 149
Prognostic factors of adult onset Still’s disease: analysis of 100 cases in 3 tertiary referral centers 148
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 147
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis. 145
Interleukin-9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psoriatic Arthritis 138
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 138
association of pathogenic and regulatory B-cell subsets with clinical and histological features in primary Sjogren's syndrome. 137
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 136
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 135
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 135
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients. 133
Short-term effectiveness of guselkumab in psoriatic arthritis patients and axial involvement: results from a real-life multicentre cohort 131
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 130
Cardiovascular disease in primary sjögren’s syndrome 130
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands 130
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis 129
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 127
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 127
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 126
Stromal Cell-derived Factor 1 in Cardiac and Autoimmune Disease 125
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 125
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis 125
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts 125
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences 125
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients. 124
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 121
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 121
Dissecting the clinical heterogeneity of adult-onset Still's disease, results from a multi-dimensional characterisation and stratification 121
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 120
Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review) 120
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 119
Stem cell therapies for systemic sclerosis 118
SENESCENT BONE MARROW DERIVED MESENCHYMAL STEM CELLS (MSC) ARE PRONE TO RECOVER DURING SSC 117
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 117
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 117
Diagnostic and interventional radiology fundamentals of synovial pathology 117
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies a very early cardiac involvement in systemic sclerosis patients of recent onset 116
Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort 116
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 115
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 115
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 114
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 114
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features. 114
Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? 114
Searching for a good model for systemic sclerosis: The molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis 113
Cytokine profile, ferritin and multi-visceral involvement characterize macrophage activation syndrome during adult-onset Still's disease 112
Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literature. 112
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 112
T helper 1 response is correlated with widespread pain, fatigue, sleeping disorders and the quality of life in patients with fibromyalgia and is modulated by hyperbaric oxygen therapy 112
Parenchymal lung disease in adult onset Still's disease: An emergent marker of disease severity - Characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients 112
Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms 111
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 111
Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases 110
Interstitial lung disease in systemic sclerosis: current and future treatment. 110
A comprehensive review on adult onset Still's disease 109
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study 108
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study 108
Response to: ‘Correspondence on ‘Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence–radiological differences’ by Ruscitti et al’ by Chen et al 108
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 107
EFFICACY AND SAFETY OF RITUXIMAB TREATMENT IN EARLY PRIMARY SJOGREN'S SYNDROME: A CLINICAL, HISTOLOGICAL AND MOLECULAR STUDY 107
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational "real-life" study 106
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center 106
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study. 106
CARDIAC MAGNETIC RESONANCE IMAGING WITH PHARMACOLOGICAL STRESS PERFUSION IN ASYMPTOMATIC PATIENTS WITH SYSTEMIC SCLEROSIS 106
Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis 106
Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm. 106
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 105
Macrophage activation syndrome in patients affected by adult-onset still disease: Analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in reumatologia clinica e sperimentale cohort 105
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 105
Nail and enthesis assessment in patients with psoriatic disease by high frequency ultrasonography: findings from a single-centre cross-sectional study 104
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. 104
Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine. 104
Still's disease continuum from childhood to elderly: data from the international AIDA Network Still's disease registry 103
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 103
The Vessels Contribute to Fibrosis in Systemic Sclerosis 103
Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial 103
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study. 102
Decreased Expression of Angiopoetin 1 on Perivascular Mesenchymal Stem Cells from Ssc Patients Induces an Anti Angiogenetic Effect, when Co-cultured with Endothelial Cells 101
Glucocorticoids in Rheumatoid Arthritis: The Silent Companion in the Therapeutic Strategy 101
The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profile 101
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 99
Computed Tomography and MR Imaging in Rheumatoid Arthritis 99
Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort 99
Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI). 98
Cardiometabolic multimorbidity may identify a more severe subset of rheumatoid arthritis, results from a “real-life” study 98
The Systemic Score May Identify Life‐Threatening Evolution in Still Disease: Data from the GIRRCS AOSD‐Study Group and the AIDA Network Still Disease Registry 97
The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection 97
Anakinra effectiveness in refractory polyserositis: An Italian multicenter study 97
Unfolding dermatologic spectrum of Behçet’s disease in Italy: real-life data from the International AIDA Network Behçet’s disease Registry 95
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 95
EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease 94
Totale 11.878
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.849
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.849
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021318 0 0 0 0 0 0 0 0 0 44 206 68
2021/2022803 39 24 153 63 17 12 31 42 66 44 61 251
2022/20233.501 226 193 60 362 209 328 49 217 1.676 21 119 41
2023/20241.043 117 46 69 99 76 325 31 54 22 59 41 104
2024/20254.770 118 79 404 213 624 449 575 308 1.120 222 344 314
2025/20268.434 507 918 823 992 887 562 1.572 368 894 911 0 0
Totale 21.970